Countries & territories / Lesser Antilles
U.S. Virgin Islands
U.S. Virgin Islands as a clinical research destination — the health system, the case for running studies here, and how PCRA Caribbean connects you to sites on the ground.
- Capital
- Charlotte Amalie
- Main languages
- English
- Currency
- US dollar (USD)
- Population
- ~85,000
Healthcare in U.S. Virgin Islands
U.S. Virgin Islands is a US territory: healthcare operates within the US system and clinical research falls under FDA jurisdiction, making it a familiar regulatory environment for US-focused programmes.
Why U.S. Virgin Islands for clinical research
The chronic-disease burden that dominates Caribbean healthcare - obesity, type 2 diabetes and hypertension - is a daily clinical reality in U.S. Virgin Islands, and most patients here have never been offered a place in a clinical study. For sponsors, that combination - genuine disease burden, largely research-naive patients, and concentrated care pathways - is exactly what makes the region worth a serious look. PCRA Caribbean is building its member-site network in U.S. Virgin Islands now: sites join by choice, are onboarded to a common ICH-GCP standard, and are matched only to studies they can genuinely deliver.
Member sites in U.S. Virgin Islands
Our anonymised directory shows the network's research-ready sites — sponsors can register for full site details, including which countries and territories each site serves.
Browse member sitesPlanning a study in U.S. Virgin Islands?
Tell us what your protocol needs and we'll give you an honest feasibility read — and if you run a hospital, clinic, pharmacy, lab or research unit in U.S. Virgin Islands, we'd love to hear from you too.